Similar Articles
1141 Resection of hepatitis B virus-related hepatocellular carcinoma: Evolving strategies and emerging therapies to improve outcome
1142 Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
1143 Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma
1144 Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment
1145 Hepatitis B viral load affects prognosis of hepatocellular carcinoma
1146 Characterization of monocarboxylate transporter activity in hepatocellular carcinoma
1147 Incorporating GSA-SPECT into CT-based dose-volume histograms for advanced hepatocellular carcinoma radiotherapy
1148 Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
1149 Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation
1150 Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA